|
|
- Anavex files Phase I regulatory submission for ANAVEX 2-73 in Alzheimer's disease
Sources News Release
Resource Type: Article
Published: 2011
Anavex Life Sciences Corp. has filed regulatory submission for ANAVEX 2-73 with the German Health Authority, BfArM, and the local Ethics Committee of Saxony to begin clinical studies for ANAVEX 2-73, its lead compound for the treatment of Alzheimer
- Bad Pharma
How drug companies mislead doctors and harm patients
Resource Type: Book
Published: 2012
Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried.
- Bad Pharma, Bad Journalism
Resource Type: Article
Published: 2012
‘The drugs don't work: a modern medical scandal’, from Ben Goldacre's new book, Bad Pharma presents a disturbing picture emerges of corporate drug abuse.
- Bayshore Home Health
Media Profile in Sources
Resource Type: Organization
- Bayshore Specialty Rx
Media Profile in Sources
Resource Type: Organization
- The Body Hunters
Testing New Drugs on the World's Poorest Patients
Resource Type: Book
This is a review on the rise of drug companies as well as the difficulties of medical research ethics. Shaw states that companies make more money developing drugs to treat American heatburn than malaria drugs. Attempts to expose drug companies have failed because of litigation. There is no mention of where and what pharmaceuticals test on the "poorest patients". Her recommendation is that medicines should be regarded as "social goods" and as such.
- Private Profits vs Public Policy
The Pharmaceutical Industry and the Canadian State
Resource Type: Book
Published: 2016
According to Joel Lexchin, "Given the central role that medicines play in keeping us healthy, it is essential that we understand the policy environment that governs drug development, from the initial basic research to the sale of the manufactured produces to the patients that use them."
- What the Tamiflu Saga tells us about Drug Trials and Big Pharma
Resource Type: Article
Published: 2014
We now know the government's Tamiflu stockpile wouldn't have done us much good in the event of a flu epidemic. But the secrecy surrounding clinical trials means there's a lot we don't know about other medicines we take, says Ben Goldacre.
|
AlterLinks
© 2021.
|
|
|
|